Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9834604 Inhibitors of T-cell activation

Patent 9834604 was granted and assigned to Genzyme on December, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Genzyme

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

98346040

Patent Inventor Names

Yunxiang Zhu0

Canwen Jiang0

Jozsef Karman0

Ronnie Wei0

Seng Cheng0

Date of Patent

December 5, 2017

Patent Application Number

141284610

Date Filed

June 29, 2012

Patent Citations Received

‌

US Patent 12110339 ICOS ligand variant immunomodulatory proteins and uses thereof

‌

US Patent 11660340 Combination therapy using T cell redirection antigen binding molecule against cell having immunosuppressing function

‌

US Patent 11789010 Methods of treatment with CD80 extracellular domain polypeptides

Patent Primary Examiner

‌

Ilia Ouspenski

Patent abstract

The present invention provides a bispecific biologic comprising a ligand specific for CTLA-4 and a ligand specific for a pMHC complex.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9834604 Inhibitors of T-cell activation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API